DM
Therapeutic Areas
ClearNote Health Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Avantect® Pancreatic Cancer Test | Early detection of pancreatic cancer | Approved/Commercial |
| Avantect® Ovarian Cancer Test | Early detection of ovarian cancer | Approved/Commercial |
| Avantect (Pipeline) | Lung Cancer Detection (Non-Small Cell Lung Cancer) | R&D |
| Virtuoso Platform | Predictive biomarkers for radioligand therapy (Pancreatic NET) | R&D/Collaboration |
Leadership Team at ClearNote Health
SL
Samuel Levy, PhD
Chief Scientific Officer
JM
Jeffrey M. Venstrom, MD
Chief Medical Officer
WV
Wayne Volkmuth, PhD
Senior Vice President, Informatics & Data Discovery
SQ
Steve Quake, D.Phil.
Founder (Inspired company from Stanford laboratory)